Current Opinions and Perspectives on the Role of Immune System in the Pathogenesis of Parkinson's Disease

被引:4
作者
Panaro, Maria Antonietta [1 ]
Cianciulli, Antonia [1 ]
机构
[1] Univ Bari, Dept Sci Med Base, I-70124 Bari, Italy
关键词
Parkinson's disease; microglia; inflammation; immune system; TUMOR-NECROSIS-FACTOR; CENTRAL-NERVOUS-SYSTEM; LIPOPOLYSACCHARIDE-INDUCED NEUROTOXICITY; NIGRAL DOPAMINERGIC-NEURONS; BLOOD-BRAIN-BARRIER; SUBSTANTIA-NIGRA; NEURODEGENERATIVE DISEASES; MOUSE MODEL; OXIDATIVE STRESS; RAT-BRAIN;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by the degeneration of dopamine neurons in the substantia nigra pars compacta. To date, although a bulk of evidences suggest that the etiology of PD is multifactorial, none of the mechanisms yet proposed have been considered conclusive. Activated glia seem to play a critical role in the degeneration of nigral dopaminergic neurons in PD, by secreting a complex array of cytokines, chemokines, proteolytic enzymes, reactive oxygen/nitrogen species and complement proteins that may have deleterious effects on the dopaminergic system. Recently, it has been reported that microglia activation and immunity are key factors contributing to disease progression. Here, we review studies on the role of inflammation mediated by the innate and adaptive immune systems involved in the pathogenesis of PD and highlight some of the important areas for future investigation.
引用
收藏
页码:200 / 208
页数:9
相关论文
共 121 条
[31]   Glatiramer acetate (Copaxone®) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis [J].
Duda, PW ;
Schmied, MC ;
Cook, SL ;
Krieger, JI ;
Hafler, DA .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (07) :967-976
[32]   Apathy May Herald Cognitive Decline and Dementia in Parkinson's Disease [J].
Dujardin, Kathy ;
Sockeel, Pascal ;
Delliaux, Marie ;
Destee, Alain ;
Defebvre, Luc .
MOVEMENT DISORDERS, 2009, 24 (16) :2391-2397
[33]   Management of Hallucinations and Psychosis in Parkinson's Disease [J].
Eng, Marty L. ;
Welty, Timothy E. .
AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY, 2010, 8 (04) :316-330
[34]   Non-steroidal anti-inflammatory drugs in Parkinson's disease [J].
Esposito, Ennio ;
Di Matteo, Vincenzo ;
Benigno, Arcangelo ;
Pierucci, Massimo ;
Crescimanno, Giuseppe ;
Di Giovanni, Giuseppe .
EXPERIMENTAL NEUROLOGY, 2007, 205 (02) :295-312
[35]   Cyclooxygenase-2-deficient mice are resistant to 1-methyl-4-phenyl1,2,3,6-tetrahydropyridine-induced damage of dopaminergic neurons in the substantia nigra [J].
Feng, ZH ;
Wang, TG ;
Li, DD ;
Fung, P ;
Wilson, BC ;
Liu, B ;
Ali, SF ;
Langenbach, R ;
Hong, JS .
NEUROSCIENCE LETTERS, 2002, 329 (03) :354-358
[36]   Early involvement of the cerebral cortex in Parkinson's disease: Convergence of multiple metabolic defects [J].
Ferrer, Isidre .
PROGRESS IN NEUROBIOLOGY, 2009, 88 (02) :89-103
[37]   The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the Motor Symptoms of Parkinson's Disease [J].
Fox, Susan H. ;
Katzenschlager, Regina ;
Lim, Shen-Yang ;
Ravina, Bernard ;
Seppi, Klaus ;
Coelho, Miguel ;
Poewe, Werner ;
Rascol, Olivier ;
Goetz, Christopher G. ;
Sampaio, Cristina .
MOVEMENT DISORDERS, 2011, 26 :S2-S41
[38]  
Furuya T, 2004, J NEUROSCI, V24, P1865, DOI 10.1523/JNEUROSCI.3309-03.2004
[39]   Vulnerability of human neurons to T cell-mediated cytotoxicity [J].
Giuliani, F ;
Goodyer, CG ;
Antel, JP ;
Yong, VW .
JOURNAL OF IMMUNOLOGY, 2003, 171 (01) :368-379
[40]  
Glinka Y, 1997, J NEURAL TRANSM-SUPP, P55